"10.1371_journal.pone.0122726","plos one","2015-04-02T00:00:00Z","Scott J Denardo; Yan Gong; Rhonda M Cooper-DeHoff; Csaba Farsang; Matyas Keltai; László Szirmai; Franz H Messerli; Anthony A Bavry; Eileen M Handberg; Giuseppe Mancia; Carl J Pepine","Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States of America; Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America; St Imre Teaching Hospital Cardiometabolic Centre, Budapest, Hungary; Semmelweis University, Hungarian Institute of Cardiology, Budapest, Hungary; N&Sz StudyMaster Medical Research Center Ltd., Szentendre, Hungary; Division of Cardiology, St Lukes-Roosevelt Hospital Center and Columbia University, College of Medicine and Physicians, New York, New York, United States of America; North Florida/South Georgia Veterans Affairs Health System, Gainesville, Florida, United States of America; Clinica Medica, Ospedale San Gerardo dei Tintori Monza, University of Milano-Bicocca, Milan, Italy","Conceived and designed the experiments: RMCD CF MK LS FHM EMH GM CJP. Performed the experiments: SJD RMCD CF MK LS FHM EMH GM CJP. Analyzed the data: SJD YG RMCD AAB FHM EMH GM CJP. Contributed reagents/materials/analysis tools: YG GM. Wrote the paper: SJD YG RMCD CF MK LS FHM AAB EMH GM CJP.","BASF Pharma and Abbott Laboratories had no role in the design or conduct of the study, collection or analysis of data, or preparation or approval of the manuscript. Dr. Szirmai: Abbott Laboratories (consulting fees; travel support). Dr. Keltai: Abbott Laboratories (travel support). Dr. Messerli: Abbott Laboratories; Novartis; Daiichi Sankyo; Pfizer; Takeda; PharmApprove; Gilead; Servier; Bayer; Medtronic; Forest (remote); Boehringer Ingelheim (remote). Dr. Bavry: Novartis Pharmaceuticals; American College of Cardiology/CardioSource (contractor). Dr. Handberg: NIH/NHLBI (grant support); Abbott; Fujisawa; Pfizer; GlaxoSmithKline (remote); US Patent #5,991,731 (royalties). Dr. Mancia: SIRON BV (consulting fees); Boehringer Ingelheim; Novartis; Takeda (lecture fees). Bayer AG; Daiichi Sankyo; Menarini; Recordati; Servier (remote). Dr. Pepine: Abbott Laboratories; Forest; Novartis/Cleveland Clinic; NicOx; Angioblast; Sanofi-Aventis; MedTelligence; Slack Inc., NIH/NHLBI (consulting fees); NIH/NHLBI, Abbott; NIH/NHLBI; Baxter; Pfizer; GlaxoSmithKline; Bioheart (grant). Drs. Handberg and Pepine: payment for development of educational programs through the Vascular Biology Working Group (educational grants: AstraZeneca; Sanofi Aventis; Schering Plough; Daiichi Sankyo; Lilly; AtCor Medical; XOMA). Drs. Denardo, Gong, Farsang, and Cooper-DeHoff: none declared. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2015","04","Scott J Denardo","SJD",11,TRUE,8,9,8,11,TRUE,TRUE,FALSE,0,NA,FALSE
